Mediar Therapeutics is a biotechnology company pioneering a new approach to fibrosis treatment that halts the disease at a different source – the fibrotic mediators that drive disease progression. Mediar was founded based on a deep understanding of the complex science underlying fibrosis onset and progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar is derisking the path forward for fibrosis therapies in clinical development. For more information, contact info@mediartx.com
View Top Employees from Mediar TherapeuticsWebsite | http://www.mediartx.com |
Employees | 50 (27 on RocketReach) |
Founded | 2019 |
Address | 20 Overland St, Boston, Massachusetts 02215, US |
Technologies |
JavaScript,
HTML,
Twitter
+4 more
(view full list)
|
Industry | Biotechnology Research |
Looking for a particular Mediar Therapeutics employee's phone or email?
Jeffrey Bornstein is the Chief Medical Officer of Mediar Therapeutics.
27 people are employed at Mediar Therapeutics.
Mediar Therapeutics is based in Boston, Massachusetts.